Parexel International

Latest Headlines

Latest Headlines

Parexel touts its IT-enabled R&D services amid company shakeup

Parexel International, in the midst of sweeping cost cuts, said it has further integrated technology into its drug development services, creating a data-informed process designed to speed up timelines and save money.

Parexel's profits slide as it slashes costs

Parexel International, in the process of shedding about 850 jobs, saw its net income dip in the fiscal first quarter, dimming its expectations for the full year.

Parexel returns to growth after a shaky quarter

Parexel International, slashing jobs after a rough run, posted some modest revenue gains in its fiscal fourth quarter, and now the CRO is looking to build some momentum with a jump in new business.

Parexel uses virtual clinical trials to improve real-life R&D

Parexel is expanding its efforts in so-called model-based drug development, using data analytics to flesh out a drug's potential safety, efficacy and interactions before beginning a clinical trial.

Parexel cutting 850 jobs as it dims its revenue outlook

CRO giant Parexel is planning to shed about 850 jobs over the next year in an effort to cut costs as it lowers its financial expectations for the quarter.

Parexel rejigs its randomization tech with an eye on speed

CRO giant Parexel has updated its technology for patient randomization and clinical supply management, touting the latest version as a valuable tool for speeding up the process of designing studies.

Parexel trims its ambitions after a flat quarter

CRO giant Parexel posted flat revenue last quarter, paring back its full-year expectations in the face of currency headwinds and client delays.

Parexel partners up for clinical trial education

CRO giant Parexel International has unveiled three new education programs in partnership with schools around the world, lending its expertise in hopes of training the next generation of clinical researchers.

Parexel buys an Indian CRO with an eye on drug safety

CRO giant Parexel International is acquiring an Indian company devoted to pharmacovigilance, looking to expand its share of the global market for managing drug safety data.

Parexel stretches out its site network to speed up enrollment

CRO giant Parexel International has expanded its Rolodex of clinical trial sites to more than 180 around the world, a network the company says allows it to more quickly find patients for studies.